| Ms Zeinth Begum Khan, DC | |
|
23111 E Main St, Armada Chiropractic, Armada, MI 48005 | |
| (586) 784-9127 | |
| (586) 784-9129 |
| Full Name | Ms Zeinth Begum Khan |
|---|---|
| Gender | Female |
| Speciality | Chiropractor |
| Location | 23111 E Main St, Armada, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417246828 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | L1853776 (Michigan) | Primary |
| Provider Name | Armada Wellness Center Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1205477932 PECOS PAC ID: 8224360532 Enrollment ID: O20191105002272 |
News Archive
CID s.r.l., a European company leader in interventional medicine, will update interventional cardiologists on the status of their revolutionary drug eluting stent technology during The Drug Eluting Stent (DES) Summit at TCT 2010, Washington, DC on Wednesday, September 22, 2010. The lecture, entitled "Status of the CID Cre8 polymer-free DES program", will be delivered by Alexandre Abizaid, MD, PhD. Chief of Intervention at Instituto Dante Pazzanese, in Sao Paulo Brazil, and will be part of the session "The Next Generation DES, Polymer-Free".
People with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by Vanderbilt researchers published in the April issue of The American Journal of Clinical Nutrition.
Exercise can be as effective as a second medication for as many as half of depressed patients whose condition have not been cured by a single antidepressant medication.
Scientists investigating the cancer-fighting properties of artesunate - a drug commonly used to treat malaria - have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels.
Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Zeinth Begum Khan, DC P.o. Box 479, 23111 E Main St Armada Chiropractic, Armada, MI 48005 Ph: (586) 784-9127 | Ms Zeinth Begum Khan, DC 23111 E Main St, Armada Chiropractic, Armada, MI 48005 Ph: (586) 784-9127 |
News Archive
CID s.r.l., a European company leader in interventional medicine, will update interventional cardiologists on the status of their revolutionary drug eluting stent technology during The Drug Eluting Stent (DES) Summit at TCT 2010, Washington, DC on Wednesday, September 22, 2010. The lecture, entitled "Status of the CID Cre8 polymer-free DES program", will be delivered by Alexandre Abizaid, MD, PhD. Chief of Intervention at Instituto Dante Pazzanese, in Sao Paulo Brazil, and will be part of the session "The Next Generation DES, Polymer-Free".
People with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by Vanderbilt researchers published in the April issue of The American Journal of Clinical Nutrition.
Exercise can be as effective as a second medication for as many as half of depressed patients whose condition have not been cured by a single antidepressant medication.
Scientists investigating the cancer-fighting properties of artesunate - a drug commonly used to treat malaria - have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels.
Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.
› Verified 3 days ago
Armada Wellness Center Pllc Chiropractor Medicare: Medicare Enrolled Practice Location: 23107 E Main St, Armada, MI 48005 Phone: 586-255-4343 | |
Dr. Julie Kay Lefever, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 22919 W Main St, Armada, MI 48005 Phone: 586-784-5470 Fax: 586-784-5471 | |
Armada Chiropractic Clinic Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 23111 E Main St, Armada, MI 48005 Phone: 586-784-9127 | |
Maqbulur R Khan, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 23111 E Main St, Armada, MI 48005 Phone: 586-784-9127 Fax: 586-784-9129 |